The intersection of nonalcoholic fatty liver disease and obesity-Reference-Cited by-同舟云学术

The intersection of nonalcoholic fatty liver disease and obesity

Published:2016-01-27 Issue:323 Volume:8 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Woo Baidal Jennifer A.¹,Lavine Joel E.¹

Affiliation:

1. Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Columbia University Medical Center, New York, NY 10032, USA.

Abstract

New insights into the overlap and differences between obesity and nonalcoholic fatty liver disease (NAFLD) are contributing to advances in diagnosis and treatment of NAFLD.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference118 articles.

1. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.

2. The global NAFLD epidemic

3. Nonalcoholic Fatty Liver Disease

4. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease

5. Prevalence of Fatty Liver in Children and Adolescents

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current strategies for nonalcoholic fatty liver disease treatment (Review);International Journal of Molecular Medicine;2024-08-08

2. Placental growth factor deficiency initiates obesity- and aging-associated metabolic syndrome;Metabolism;2024-08

3. From NAFLD to MASLD: When metabolic comorbidity matters;Annals of Hepatology;2024-03

4. A nanoemulsion targeting adipose hypertrophy and hyperplasia shows anti-obesity efficiency in female mice;Nature Communications;2024-01-02

5. Development and Validation of a Risk Prediction Model for NAFLD: A Study Based on a Physical Examination Population;Diabetes, Metabolic Syndrome and Obesity;2024-01